Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier‐type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T‐cell lymphoma
暂无分享,去创建一个
A. Zelenetz | D. Mould | S. Horwitz | F. Sirotnak | O. O’Connor | P. Hamlin | C. Moskowitz | A. Noy | C. Portlock | D. Straus | B. Macgregor-Cortelli | E. Neylon | D. Sarasohn | M. Fleischer | Otila Dumetrescu | Barbara Macgregor-Cortelli